More recently, BCL1/IgH, and IgH-VDJ along with SOX11 and Cyclin D1 have been discussed as biomarkers for MRD-guided management of patients with mature B cell malignancies including MCL [55]. The gene discussed is CCND1; the disease is mantle cell lymphoma.